CIRUGÍA Y ODONTOESTOMATOLOGÍA
Escuela de doctorado
JESÚS FERNANDO
SAN MIGUEL IZQUIERDO
Investigador en el periodo 1986-2013
Publicaciones en las que colabora con JESÚS FERNANDO SAN MIGUEL IZQUIERDO (12)
2014
2013
-
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients
Haematologica, Vol. 98, Núm. 3, pp. 437-443
-
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry
Haematologica, Vol. 98, Núm. 1, pp. 79-86
-
The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects
Leukemia, Vol. 27, Núm. 2, pp. 430-440
2012
-
Dasatinib as a bone-modifying agent: Anabolic and anti-resorptive effects
PLoS ONE, Vol. 7, Núm. 4
2011
-
Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma
Leukemia, Vol. 25, Núm. 4, pp. 697-706
-
Limbus Damage in Ocular Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation, Vol. 17, Núm. 2, pp. 270-273
2010
2009
-
Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
Leukemia, Vol. 23, Núm. 8, pp. 1515-1527
2008
-
Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification
Experimental Hematology, Vol. 36, Núm. 8, pp. 1014-1021
2007
-
Use of bortezomib in the management of chronic graft-versus-host disease among multiple myeloma patients relapsing after allogeneic transplantation
Haematologica, Vol. 92, Núm. 9, pp. 1295-1296
2006
-
Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation
Blood Coagulation and Fibrinolysis, Vol. 17, Núm. 1, pp. 23-28